The asthma spacers market in Europe is expected to grow from US$ 484.78 million in 2022 to US$ 651.16 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2022 to 2028.
Rising awareness regarding the benefits of spacers is the major factor driving the growth of the Europe asthma spacers market. Inhaler spacers play a vital role in the quick and effective delivery of the inhaled drug into the lungs. Spacers are majorly recommended along with the metered dose inhalers as they have significant capacity to spray the medicine, which gets deposited in the throat or palate. Further, the spacers extensively offer improved ergonomics for the patient, enabling enhanced treatment outcomes.
The rapidly increasing prevalence of respiratory conditions is driving the adoption of inhalers. However, many patients lack preparedness while using inhalers, causing medication errors. For instance, according to a study published in the online newsletter Business Standard in 2019, an estimated 42% of the patients missed critical medication steps, which led to lowered treatment outcomes. Spacers can offer smooth and slower absorption of drugs in the lungs to deal with such issues. Such benefits served by the spacers offer significant market growth opportunities.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe asthma spacers market . The Europe asthma spacers market is expected to grow at a good CAGR during the forecast period.
Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin, Metall Zug, Monaghan Medical Corporation, PARI GmbH, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.
Rising awareness regarding the benefits of spacers is the major factor driving the growth of the Europe asthma spacers market. Inhaler spacers play a vital role in the quick and effective delivery of the inhaled drug into the lungs. Spacers are majorly recommended along with the metered dose inhalers as they have significant capacity to spray the medicine, which gets deposited in the throat or palate. Further, the spacers extensively offer improved ergonomics for the patient, enabling enhanced treatment outcomes.
The rapidly increasing prevalence of respiratory conditions is driving the adoption of inhalers. However, many patients lack preparedness while using inhalers, causing medication errors. For instance, according to a study published in the online newsletter Business Standard in 2019, an estimated 42% of the patients missed critical medication steps, which led to lowered treatment outcomes. Spacers can offer smooth and slower absorption of drugs in the lungs to deal with such issues. Such benefits served by the spacers offer significant market growth opportunities.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe asthma spacers market . The Europe asthma spacers market is expected to grow at a good CAGR during the forecast period.
Europe Asthma Spacers Market Segmentation
Europe asthma spacers market is segmented into product, distribution channel, and country. Based on product, the Europe asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the Europe asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the Europe asthma spacers market is segmented into France, Germany, Italy, the UK, Spain, and the Rest of Europe. Germany held the largest market share in 2022.Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin, Metall Zug, Monaghan Medical Corporation, PARI GmbH, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Asthma Spacers Market - Market Landscape
5. Europe Asthma Spacers Market - Key Market Dynamics
6. Asthma Spacers Market- Europe Analysis
7. Europe Asthma Spacers Market Revenue and Forecast To 2028 - by Product
8. Europe Asthma Spacers Market Analysis and Forecast to 2028 - by Distribution Channel
9. Europe Asthma Spacers Market Revenue and Forecasts to 2028 - Country Analysis
10. Asthma Spacers Market-Industry Landscape
11. Company Profiles
12. Appendix
List of Figures
List of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agaplastic
- Cipla Inc.
- Koninklijke Philips N.V.
- Koo Medical Equipment
- Laboratoire ProtecSom
- Lupin
- Metall Zug
- Monaghan Medical Corporation
- PARI GmbH
- Teleflex Incorporated
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 484.78 Million |
| Forecasted Market Value ( USD | $ 651.16 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Europe |
